These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19584658

  • 1. Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy.
    Das R, Shi Y, Silvestri G, Chakravarthy U.
    Retina; 2009; 29(7):1013-8. PubMed ID: 19584658
    [Abstract] [Full Text] [Related]

  • 2. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Parravano M, Oddone F, Tedeschi M, Schiano Lomoriello D, Chiaravalloti A, Ripandelli G, Varano M.
    Retina; 2009 Mar; 29(3):329-34. PubMed ID: 19092732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.
    Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ, Gabel VP, Heier JS, Ip MS, Loewenstein A, Packo KH, Stur M, Toaff T, Preferential Hyperacuity Perimetry Research Group.
    Ophthalmology; 2005 Oct; 112(10):1758-65. PubMed ID: 16154198
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of Preferential Hyperacuity Perimeter (PHP) test and Amsler grid test in the diagnosis of different stages of age-related macular degeneration].
    Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE.
    Klin Monbl Augenheilkd; 2006 Sep; 223(9):752-6. PubMed ID: 16986086
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease.
    Ahlers C, Golbaz I, Einwallner E, Dunavölgyi R, Malamos P, Stock G, Pruente C, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3417-24. PubMed ID: 19168899
    [Abstract] [Full Text] [Related]

  • 12. Preferential hyperacuity perimeter in best vitelliform macular dystrophy.
    Querques G, Atmani K, Bouzitou-Mfoumou R, Leveziel N, Massamba N, Souied EH.
    Retina; 2011 May; 31(5):959-66. PubMed ID: 21242858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re: Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab.
    Uparkar M, Bhende M.
    Retina; 2009 May; 29(10):1549; author reply 1549-50. PubMed ID: 19898197
    [No Abstract] [Full Text] [Related]

  • 15. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 May; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 16. Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration.
    Joeres S, Llacer H, Heussen FM, Weiss C, Kirchhof B, Joussen AM.
    Eye (Lond); 2008 Jun; 22(6):782-9. PubMed ID: 17332766
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
    Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ.
    Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY, Dubois L, Tadayoni R, Fajnkuchen F, Nghiem-Buffet S, Delahaye-Mazza C, Guiberteau B, Quentel G.
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.